Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
2.
Foodborne Pathog Dis ; 8(12): 1295-301, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21883007

ABSTRACT

BACKGROUND: In addition to medical antimicrobial usage, the use of antimicrobials in food animals contributes to the occurrence of resistance among some bacterial species isolated from infections in humans. Recently, several studies have indicated that a large proportion of Escherichia coli causing infections in humans, especially those resistant to antimicrobials, have an animal origin. METHODS: We analyzed the correlation between the prevalence of antimicrobial resistance in E. coli isolates from blood stream infections in humans and in E. coli isolates from poultry, pigs, and cattle between 2005 and 2008 for 11 countries, using available surveillance data. We also assessed the correlation between human antimicrobial usage and the occurrence of resistance in E. coli isolates from blood stream infections. RESULTS: Strong and significant correlations between prevalences of resistance to ampicillin (r=0.94), aminoglycosides (r=0.72), third-generation cephalosporins (r=0.76), and fluoroquinolones (r=0.68) were observed for human and poultry E. coli isolates. Similar significant correlations were observed for ampicillin (r=0.91), aminoglycosides (r=0.73), and fluoroquinolone resistance (r=0.74) in pig and human isolates. In cattle isolates, only ampicillin resistance (r=0.72) was significantly correlated to human isolates. When usage of antimicrobials in humans was analyzed with antimicrobial resistance among human isolates, only correlations between fluoroquinolones (r=0.90) and third-generation cephalosporins (r=0.75) were significant. CONCLUSIONS: Resistance in E. coli isolates from food animals (especially poultry and pigs) was highly correlated with resistance in isolates from humans. This supports the hypothesis that a large proportion of resistant E. coli isolates causing blood stream infections in people may be derived from food sources.


Subject(s)
Anti-Infective Agents/pharmacology , Cattle Diseases/microbiology , Escherichia coli Infections/microbiology , Escherichia coli/drug effects , Poultry Diseases/microbiology , Swine Diseases/microbiology , Animal Husbandry , Animals , Bacteremia/microbiology , Cattle , Cattle Diseases/epidemiology , Drug Resistance, Bacterial , Escherichia coli/isolation & purification , Escherichia coli Infections/epidemiology , Europe/epidemiology , Food Microbiology , Humans , Meat/microbiology , Microbial Sensitivity Tests , Poultry , Poultry Diseases/epidemiology , Prevalence , Regression Analysis , Swine , Swine Diseases/epidemiology
3.
Foodborne Pathog Dis ; 8(8): 887-900, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21492021

ABSTRACT

Salmonella enterica is commonly acquired from contaminated food and is an important cause of illness worldwide. Interventions are needed to control Salmonella; subtyping Salmonella by serotyping is useful for targeting such interventions. We, therefore, analyzed the global distribution of the 15 most frequently identified serovars of Salmonella isolated from humans from 2001 to 2007 in laboratories from 37 countries that participated in World Health Organization Global Foodborne Infections Network and demonstrated serotyping proficiency in the Global Foodborne Infections Network External Quality Assurance System. In all regions throughout the study period, with the exception of the Oceania and North American regions, Salmonella serovars Enteritidis and Typhimurium ranked as the most common and second most common serovar, respectively. In the North American and Oceania (Australia and New Zealand) regions, Salmonella serovar Typhimurium was the most common serovar reported, and Salmonella serovar Enteritidis was the second most common serovar. During the study period, the proportion of Salmonella isolates reported from humans that were Salmonella serovar Enteritidis was 43.5% (range: 40.6% [2007] to 44.9% [2003]), and Salmonella serovar Typhimurium was 17.1% (range: 15% [2007] to 18.9% [2001]). Salmonella serovars Newport (mainly observed in Latin and North American and European countries), Infantis (dominating in all regions), Virchow (mainly observed in Asian, European, and Oceanic countries), Hadar (profound in European countries), and Agona (intense in Latin and North American and European countries) were also frequently isolated with an overall proportion of 3.5%, 1.8%, 1.5%, 1.5%, and 0.8%, respectively. There were large differences in the most commonly isolated serovars between regions, but lesser differences between countries within the same region. The results also highlight the complexity of the global epidemiology of Salmonella and the need and importance for improving monitoring data of those serovars of highest epidemiologic importance.


Subject(s)
Food Microbiology , Salmonella/classification , Serotyping , Databases, Factual , Humans , Laboratories , Quality Control , Salmonella/isolation & purification , Salmonella Infections/epidemiology , Salmonella Infections/microbiology , Salmonella enteritidis/isolation & purification , Salmonella typhimurium/isolation & purification , World Health Organization
4.
Am J Vet Res ; 71(7): 726-33, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20594073

ABSTRACT

OBJECTIVE: To evaluate changes in antimicrobial consumption and productivity by Danish swine farms during 1992 to 2008. SAMPLE POPULATION: All Danish swine farms for antimicrobial consumption data and a representative sample of Danish swine herds for productivity data. PROCEDURES: Antimicrobial consumption by Danish swine farms from 1992 to 2008 was determined and evaluated in light of policies to regulate antimicrobial consumption, changes in disease patterns, and productivity data. Trend analyses of productivity data were conducted before and after a ban on use of antimicrobial growth promoters (AGPs). Results-Antimicrobial consumption peaked at 100 mg/kg of swine produced in 1992, decreased to 31 mg/kg in 1999, and increased to 49 mg/kg in 2008. Key factors for changes were regulations banning subtherapeutic use of antimicrobials and veterinary profits from the prescription and sale of antimicrobials in 1994 and termination of AGP use by January 2000. Pig production increased from 18.4 to 271 million pigs, and the mean number of pigs per sow per year raised for slaughter increased from 21 in 1992 to 25 in 2007 Average daily gain for weaning (< 35 kg) and finishing (> 35 kg) pigs was higher in 2008 than in 1992, but mortality rates for weaning and finishing pigs were similar in 1992 and 2008. CONCLUSIONS AND CLINICAL RELEVANCE: From 1992 to 2008, antimicrobial consumption per kilogram of pig produced in Denmark decreased by > 50%. Furthermore, there was improvement in productivity, suggesting that long-term swine productivity was not negatively impacted by a ban on AGP use.


Subject(s)
Anti-Infective Agents/therapeutic use , Swine Diseases/drug therapy , Animals , Anti-Infective Agents/pharmacology , Denmark , Female , Growth/drug effects , Male , Meat , Regression Analysis , Reproduction/drug effects , Reproduction/physiology , Software , Swine , Swine Diseases/mortality , Weight Gain
5.
Meat Sci ; 84(2): 276-83, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20374786

ABSTRACT

During the last two decades the major food safety problems in Denmark, as determined by the number of human patients, has been associated with bacterial infections stemming from meat products and eggs. The bacterial pathogens causing the majority of human infections has been Salmonella and Campylobacter, and to a lesser extent Yersinia, Escherichiacoli O157 and Listeria. Danish initiatives to improve the safety of meat products have focused on the entire production chain from the farm to the consumer, with a special emphasis on the pre-harvest stage of production. The control of bacterial pathogens which are resistant to antibiotics has been a new area of attention in the recent decade, and recently, the increasing globalization of the domestic food supply has called for a complete rethinking of the national food safety strategies. The implementations of a "case-by-case" risk assessment system, as well as increased international collaboration on surveillance, are both elements in this new strategy.


Subject(s)
Consumer Product Safety , Food Contamination/prevention & control , Food Handling/standards , Meat Products/microbiology , Meat Products/standards , Animals , Campylobacter/growth & development , Campylobacter/isolation & purification , Denmark , Escherichia coli O157/growth & development , Escherichia coli O157/isolation & purification , Food Handling/methods , Food Microbiology , Food Supply/standards , Humans , Listeria/growth & development , Listeria/isolation & purification , Risk Assessment , Salmonella/growth & development , Salmonella/isolation & purification , Yersinia/growth & development , Yersinia/isolation & purification
6.
J Clin Microbiol ; 47(9): 2729-36, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19571024

ABSTRACT

An international external quality assurance system (EQAS) for the serotyping of Salmonella species was initiated in 2000 by WHO Global Salm-Surv to enhance the capacity of national reference laboratories to obtain reliable data for surveillance purposes worldwide. Seven EQAS iterations were conducted between 2000 and 2007. In each iteration, participating laboratories submitted serotyping results for eight Salmonella isolates. A total of 249 laboratories in 96 countries participated in at least one EQAS iteration. A total of 756 reports were received from the participating laboratories during the seven EQAS iterations. Cumulatively, 76% of participating laboratories submitted data for all eight strains, and 82% of strains were correctly serotyped. In each iteration, 84% to 96% of the laboratories correctly serotyped the Salmonella enterica serovar Enteritidis isolate that was included as an internal quality control strain. Regional differences in performance were observed, with laboratories in Central Asia and the Middle East performing less well overall than those in other regions. Errors that resulted in incorrect serovar identification were typically caused by difficulties in the detection of the phase two flagellar antigen or in differentiation within antigen complexes; some of these errors are likely related to the quality of the antisera available. The results from the WHO Global Salm-Surv EQAS, the largest of its kind in the world, show that most laboratories worldwide are capable of correctly serotyping Salmonella species. However, this study also indicates a continuing need for improvement. Future training efforts should be aimed at enhancing the ability to detect the phase two flagellar antigen and at disseminating information on where to purchase high-quality antisera.


Subject(s)
Bacteriological Techniques/standards , Quality Assurance, Health Care/methods , Salmonella Infections/diagnosis , Salmonella Infections/microbiology , Salmonella/classification , Salmonella/isolation & purification , Diagnostic Errors/statistics & numerical data , Health Services Research , Humans , Reference Standards , Serotyping/standards , World Health Organization
7.
J Clin Microbiol ; 47(1): 79-85, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19020068

ABSTRACT

An international External Quality Assurance System (EQAS) for antimicrobial susceptibility testing of Salmonella was initiated in 2000 by the World Health Organization (WHO) Global Salm-Surv in order to enhance the capacities of national reference laboratories to obtain reliable data for surveillance purposes worldwide. Seven EQAS iterations have been conducted from 2000 to 2007. In each iteration, participating laboratories submitted susceptibility results from 10 to 15 antimicrobial agents for eight Salmonella isolates and an Escherichia coli reference strain (ATCC 25922). A total of 287 laboratories in 102 countries participated in at least one EQAS iteration. A large number of laboratories reported results for the E. coli ATCC 25922 reference strain which were outside the quality control ranges. Critical deviations for susceptibility testing of the Salmonella isolates varied from 4% in 2000 to 3% in 2007. Consistent difficulties were observed in susceptibility testing of amoxicillin-clavulanic acid, cefotaxime, ceftazidime, streptomycin, sulfonamides, and tetracycline. Regional variations in performance were observed, with laboratories in central Asia, Africa, and the Middle East not performing as well as those in other regions. Results from the WHO Global Salm-Surv EQAS show that most laboratories worldwide are capable of correctly performing antimicrobial susceptibility testing of Salmonella isolates, but they also indicate that further improvement for some laboratories is needed. In particular, further training and dissemination of information on quality control, appropriate interpretive criteria (breakpoints), and harmonization of the methodology worldwide through WHO Global Salm-Surv and other programs will contribute to the generation of comparable and reliable antimicrobial susceptibility data.


Subject(s)
Anti-Bacterial Agents/pharmacology , Microbial Sensitivity Tests/standards , Salmonella/drug effects , Diagnostic Errors , Escherichia coli/drug effects , Guidelines as Topic , Humans , Quality Control , Reference Standards , Reproducibility of Results , World Health Organization
8.
Foodborne Pathog Dis ; 6(1): 99-109, 2009.
Article in English | MEDLINE | ID: mdl-19072081

ABSTRACT

It has been recognized that exposure to antimicrobial agents can exert a selective pressure for the emergence of antimicrobial resistance. The objective of this study was to investigate an association between the probability of isolating a tetracycline-resistant Escherichia coli isolate from the intestinal tract of healthy pigs and patterns of tetracycline consumption in the herds of origin, together with other risk factors. Data on antimicrobial resistance, antimicrobial consumption, and pig herd demographics were obtained from different Danish surveillance programs. Descriptive statistics were performed for the risk factors in relation to the susceptibility status. Logistic regression analysis was performed to identify risk factors with significant effect on the log odds of tetracycline resistance of E. coli isolates. The model showed that an increase in the interval between last prescription and sampling date would decrease the probability of isolating a resistant E. coli isolate (p-value = 0.01). Also, a direct association between treatment incidence rate in a herd and probability of resistance was detected (p-value = 0.03). Other risk factors found to have a significant effect in the isolate susceptibility status were number of produced animals in the year and year of sampling. Other antimicrobial consumption risk factors, such as number of prescriptions and amount prescribed, although not included in the final model, presented indirect impact in the tetracycline resistance probability. From this study, we can infer that tetracycline usage, the time span between last treatment and sampling date, together with herd size and the proportion of animals being treated in a herd, increase the probability of obtaining a resistant isolate.


Subject(s)
Abattoirs , Escherichia coli/drug effects , Swine/microbiology , Tetracycline Resistance , Tetracycline/pharmacology , Animals , Denmark , Escherichia coli/growth & development , Escherichia coli/isolation & purification , Humans , Logistic Models , Odds Ratio , Risk Factors , Seasons , Tetracycline/administration & dosage , Time Factors
9.
Expert Rev Anti Infect Ther ; 6(5): 733-50, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18847409

ABSTRACT

Bacteria have evolved multiple mechanisms for the efficient evolution and spread of antimicrobial resistance. Modern food production facilitates the emergence and spread of resistance through the intensive use of antimicrobial agents and international trade of both animals and food products. The main route of transmission between food animals and humans is via food products, although other modes of transmission, such as direct contact and through the environment, also occur. Resistance can spread as resistant pathogens or via transferable genes in different commensal bacteria, making quantification of the transmission difficult. The exposure of humans to antimicrobial resistance from food animals can be controlled by either limiting the selective pressure from antimicrobial usage or by limiting the spread of the bacteria/genes. A number of control options are reviewed, including drug licensing, removing financial incentives, banning or restricting the use of certain drugs, altering prescribers behavior, improving animal health, improving hygiene and implementing microbial criteria for certain types of resistant pathogens for use in the control of trade of both food animals and food.


Subject(s)
Animal Husbandry/standards , Anti-Bacterial Agents , Drug Resistance, Bacterial , Food Chain , Gram-Negative Bacteria/drug effects , Meat/microbiology , Animal Husbandry/methods , Animals , Animals, Domestic , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Chickens/microbiology , Drug Resistance, Bacterial/genetics , Gram-Negative Bacteria/genetics , Humans , Intestines/microbiology , Swine/microbiology
10.
Emerg Infect Dis ; 13(11): 1632-9, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18217544

ABSTRACT

Resistance to antimicrobial agents is an emerging problem worldwide. Awareness of the undesirable consequences of its widespread occurrence has led to the initiation of antimicrobial agent resistance monitoring programs in several countries. In 1995, Denmark was the first country to establish a systematic and continuous monitoring program of antimicrobial drug consumption and antimicrobial agent resistance in animals, food, and humans, the Danish Integrated Antimicrobial Resistance Monitoring and Research Program (DANMAP). Monitoring of antimicrobial drug resistance and a range of research activities related to DANMAP have contributed to restrictions or bans of use of several antimicrobial agents in food animals in Denmark and other European Union countries.


Subject(s)
Bacterial Infections/microbiology , Drug Resistance, Multiple, Bacterial , Food Microbiology , Animal Husbandry/methods , Animals , Anti-Infective Agents/administration & dosage , Bacterial Infections/drug therapy , Denmark , European Union , Humans/microbiology , Meat/microbiology , Microbial Sensitivity Tests , Veterinary Drugs
12.
Clin Infect Dis ; 43(7): 911-6, 2006 Oct 01.
Article in English | MEDLINE | ID: mdl-16941376

ABSTRACT

The use of antimicrobial agents in the modern farm industry has created a reservoir of resistant bacteria in food animals. Foods of animal origin are often contaminated with enterococci that are likely to contribute resistance genes, virulence factors, or other properties to enterococci IN humans. The potential hazard to human health from antimicrobial-resistant enterococci in animals is questioned by some scientists because of evidence of host specificity of enterococci. Similarly, the occurrences of specific nosocomial clones of enterococci in hospitals have lead to the misconception that antimicrobial-resistant animal enterococci should be disregarded as a human health hazard. On the basis of review of the literature, we find that neither the results provided by molecular typing that classify enterococci as host-specific organisms nor the occurrence of specific nosocomial clones of enterococci provide reasons to change the current view that antimicrobial-resistant enterococci from animals pose a threat to human health. On the contrary, antimicrobial resistance genes appear to spread freely between enterococci from different reservoirs, irrespective of their apparent host association.


Subject(s)
Animal Feed/microbiology , Anti-Infective Agents/pharmacology , Drug Resistance, Bacterial , Enterococcus/physiology , Adaptation, Physiological , Animals , Animals, Domestic , Drug Resistance, Bacterial/genetics , Enterococcus/drug effects , Enterococcus/genetics , Enterococcus/pathogenicity , Gene Transfer Techniques , Hazardous Substances , Hospitals , Humans
13.
Emerg Infect Dis ; 12(3): 381-8, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16704773

ABSTRACT

Salmonellae are a common cause of foodborne disease worldwide. The World Health Organization (WHO) supports international foodborne disease surveillance through WHO Global Salm-Surv and other activities. WHO Global Salm-Surv members annually report the 15 most frequently isolated Salmonella serotypes to a Web-based country databank. We describe the global distribution of reported Salmonella serotypes from human and nonhuman sources from 2000 to 2002. Among human isolates, S. Enteritidis was the most common serotype, accounting for 65% of all isolates. Among nonhuman isolates, although no serotype predominated, Salmonella enterica serovar Typhimurium was reported most frequently. Several serotypes were reported from only 1 region of the world. The WHO Global Salm-Surv country databank is a valuable public health resource; it is a publicly accessible, Web-based tool that can be used by health professionals to explore hypotheses related to the sources and distribution of salmonellae worldwide.


Subject(s)
Global Health , Internet , Population Surveillance/methods , Salmonella Infections/epidemiology , Salmonella Infections/microbiology , Salmonella/isolation & purification , Africa/epidemiology , Asia/epidemiology , Caribbean Region/epidemiology , Europe/epidemiology , Humans , Latin America/epidemiology , North America/epidemiology , Oceania , World Health Organization
15.
Emerg Infect Dis ; 12(2): 280-5, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16494755

ABSTRACT

We report the findings of a case-control study of risk factors for sporadic cases of human campylobacteriosis in Denmark. In 3 different analytical models, the main domestic risk factor identified was eating fresh, unfrozen chicken. Specifically, 28 of 74 domestically acquired case-patients were exposed to fresh chicken compared with 21 of 114 controls (multivariate matched odds ratio 5.8; 95% confidence interval 2.1-15.9). In contrast, a risk from eating other poultry, including previously frozen chicken, was only indicated from borderline significant 2-factor interactions. The marked increase in consumption of fresh, unfrozen poultry in Denmark during the 1990s likely contributed substantially to the increasing incidence of human campylobacteriosis in this period.


Subject(s)
Campylobacter Infections , Campylobacter/isolation & purification , Chickens/microbiology , Food Handling/methods , Poultry Diseases/microbiology , Animals , Campylobacter Infections/epidemiology , Campylobacter Infections/microbiology , Campylobacter Infections/veterinary , Case-Control Studies , Denmark/epidemiology , Food Microbiology , Humans , Poultry Diseases/epidemiology , Risk Factors
16.
Clin Infect Dis ; 41(7): 1007-13, 2005 Oct 01.
Article in English | MEDLINE | ID: mdl-16142667

ABSTRACT

Some persons argue that the routine addition of antibiotics to animal feed will help alleviate protein undernutrition in developing countries by increasing meat production. In contrast, we estimate that, if all routine antibiotic use in animal feed were ceased, there would be negligible effects in these countries. Poultry and pork production are unlikely to decrease by more than 2%. Average daily protein supply would decrease by no more than 0.1 g per person (or 0.2% of total protein intake). Eliminating the routine use of in-feed antibiotics will improve human and animal health, by reducing the development and spread of antibiotic-resistant bacteria.


Subject(s)
Animal Feed , Anti-Bacterial Agents/administration & dosage , Developing Countries , Protein Deficiency/epidemiology , Protein Deficiency/prevention & control , Veterinary Drugs/administration & dosage , Agriculture , Animals , Cattle , Dietary Proteins , Drug Resistance, Bacterial , Meat/supply & distribution , Nutritional Physiological Phenomena , Poultry/growth & development , Poverty , Swine/growth & development , Time Factors
20.
Risk Anal ; 24(1): 255-69, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15028016

ABSTRACT

Based on the data from the integrated Danish Salmonella surveillance in 1999, we developed a mathematical model for quantifying the contribution of each of the major animal-food sources to human salmonellosis. The model was set up to calculate the number of domestic and sporadic cases caused by different Salmonella sero and phage types as a function of the prevalence of these Salmonella types in the animal-food sources and the amount of food source consumed. A multiparameter prior accounting for the presumed but unknown differences between serotypes and food sources with respect to causing human salmonellosis was also included. The joint posterior distribution was estimated by fitting the model to the reported number of domestic and sporadic cases per Salmonella type in a Bayesian framework using Markov Chain Monte Carlo simulation. The number of domestic and sporadic cases was obtained by subtracting the estimated number of travel- and outbreak-associated cases from the total number of reported cases, i.e., the observed data. The most important food sources were found to be table eggs and domestically produced pork comprising 47.1% (95% credibility interval, CI: 43.3-50.8%) and 9% (95% CI: 7.8-10.4%) of the cases, respectively. Taken together, imported foods were estimated to account for 11.8% (95% CI: 5.0-19.0%) of the cases. Other food sources considered had only a minor impact, whereas 25% of the cases could not be associated with any source. This approach of quantifying the contribution of the various sources to human salmonellosis has proved to be a valuable tool in risk management in Denmark and provides an example of how to integrate quantitative risk assessment and zoonotic disease surveillance.


Subject(s)
Food Microbiology , Salmonella Food Poisoning/etiology , Salmonella/isolation & purification , Animals , Bayes Theorem , Denmark/epidemiology , Disease Outbreaks , Eggs/microbiology , Humans , Markov Chains , Meat/microbiology , Models, Biological , Monte Carlo Method , Risk Assessment , Salmonella/classification , Salmonella/pathogenicity , Salmonella Food Poisoning/epidemiology , Sus scrofa
SELECTION OF CITATIONS
SEARCH DETAIL
...